Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BTIG Downgrades Magenta Therapeutics to Neutral

BTIG analyst Yun Zhong downgrades Magenta Therapeutics (NASDAQ:MGTA) from Buy to Neutral.

byBenzinga Newsdesk

January 26, 2023

1 minute read

BTIG analyst Yun Zhong downgrades Magenta Therapeutics (NASDAQ:MGTA) from Buy to Neutral.

PLAYSTUDIOS Sees FY21 Sales $290M-$300M vs $327.7M Est.

By Bill Haddad

Today, 1:34 PM

The Company expects its full-year 2021 revenue to be in the range of $290 million to $300 million. In addition, full-year AEBITDA is expected to be in the range of $35 million to $40 million.

MYPS

Morgan Stanley Maintains Overweight on Coca-Cola, Raises Price Target to $64

By Benzinga Newsdesk

Today, 1:34 PM

Morgan Stanley analyst Dara Mohsenian maintains Coca-Cola (NYSE:KO) with a Overweight and raises the price target from $60 to $64.

Mayville Engineering Cuts Top End Of FY21 Outlook Citing Supply Chain Challenges

By Akanksha Bakshi

Today, 1:34 PM

Mayville Engineering Co Inc (NYSE:MEC) narrowed its 2021 financial outlook and introduced its 2022 financial outlook. FY21 Outlook: The company expects…

MEC